Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2010-2-12
pubmed:abstractText
Confocal laser endomicroscopy (CLE) is rapidly emerging as a valuable tool for gastrointestinal endoscopic imaging. Fluorescent contrast agents are used to optimize imaging with CLE, and intravenous fluorescein is the most widely used contrast agent. Fluorescein is FDA-cleared for diagnostic angiography of the retina. For these indications, the safety profile of fluorescein has been well-documented; however, to date, fluorescein is not cleared for use with CLE.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1365-2036
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
548-52
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract.
pubmed:affiliation
Department of Medicine, Mayo Clinic, Jacksonville, FL, USA. Wallace.michael@mayo.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Multicenter Study